• Aucun résultat trouvé

A Comment on Marschall et al

N/A
N/A
Protected

Academic year: 2021

Partager "A Comment on Marschall et al"

Copied!
1
0
0

Texte intégral

(1)

A Comment on Marschall et al To the Editor—We read with interest the recent article by Marschall et al [1] on the impact of prebiopsy antibiotics on pathogen recovery in hematoge-nous vertebral osteomyelitis. The authors found that antibiotic therapy before diagnostic biopsy for vertebral osteomye-litis did not affect the microbiologic yield of an open bone biopsy. The authors ac-knowledge some limitations; for example, the higher diagnostic yield may have re-flected the fact that patients with more extensive infection were more likely to require surgery, leading to improved sampling and presumably higher bacterial load.

The main goals of diagnostic evalua-tion for spinal osteomyelitis are to iden-tify the causative microorganism and determine the extent of infection. Micro-biologic diagnosis through computed tomography–guided percutaneous biopsy or open biopsy is essential for the man-agement and pathogen-specific therapy of such severe infections. In the study of Marschall et al [1], methicillin-resistant Staphylococcus aureus (MRSA) was the predominant pathogen recovered from biopsy specimens, and vancomycin was the antibiotic most frequently used before biopsy. In our view, these findings are relevant for the interpretation of this study. MRSA is not rapidly killed by vancomycin [2], and therefore the appli-cation of vancomycin before biopsy is unlikely to sterilize the culture and explain

the results. However, other bacteria, such as streptococci [3,4], are highly suscepti-ble to b-lactams, and cultures negative for streptococci after initiation of antimicro-bial treatment are common. In this con-text, antibiotics had to be discontinued at least 14 days before biopsy to optimize the microbiologic yield for diagnosis of device-associated osteomyelitis [5].

For these reasons, the data presented by Marschall et al [1] have to be in-terpreted with caution and may not be generalizable to settings where the prevalence of MRSA and use of vamco-mycin is less frequent. Obtaining biopsy specimens before initiating empirical antibiotic treatment should remain the state of the art [6].

Notes

Potential conflicts of interest. All authors: No reported conflicts.

All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Baharak Babouee,1Luigia Elzi,1Reno Frei,2

Andreas Widmer,1and Manuel Battegay1 1Department of Medicine, Division of Infectious

Diseases and Hospital Epidemiology, University Hospital Basel, and2Department of Laboratory

Medicine, Division of Clinical Microbiology, University Hospital Basel, Basel, Switzerland

References

1. Marschall J, Bhavan KP, Olsen MA, et al. The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis. Clin Infect Dis 2011; 52: 867–72.

2. Wiederhold NP, Coyle EA, Raad II, et al. Antibacterial activity of linezolid and vanco-mycin in an in vitro pharmacodynamic model of gram-positive catheter-related bac-teraemia. J Antimicrob Chemother 2005; 55: 792–5.

3. Webb LX, Holman J, de Araujo B, et al. Antibiotic resistance in staphylococci adher-ent to cortical bone. J Orthop Trauma 1994; 8:28–33.

4. Graziani AL, Lawson LA, Gibson GA, et al. Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother 1988; 32:1320–2.

5. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee pros-theses for diagnosis of infection. N Engl J Med 2007; 357:654–63.

6. Zimmerli W. Vertebral osteomyelitis. N Engl J Med 2010; 362:1022–9.

Correspondence: Manuel Battegay, MD, Division of In-fectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland (mbattegay@uhbs.ch).

Clinical Infectious Diseases 2011;53(7):748 Ó The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals. permissions@oup.com.

1058-4838/2011/537-0020$14.00 DOI: 10.1093/cid/cir512

Références

Documents relatifs

The domi- nant CA-MRSA clone in the United States, referred to as the USA300 North American (USA300-NA) MRSA clone in this study, belongs to pandemic multilocus sequence type 8

Dans la forêt profonde, les renards et les blaireaux creusent leur terrier?. Qui joue de la flûte dans

Family structure (parents together) 75.8 Satisfactory relationship with mother 85.1 Satisfactory relationship with father 77.5 Satisfactory relationship with peers 92.0 Smoking in

Anderer- seits wurden diejenigen aufhOrwilligen Raucher/-innen, die sich w~hrend der Kampagne in der Apotheke Ober die RaucherentwOhnung beraten liessen, mittels

McNeil, Frey and Embrechts set out with the history of risk management including an interestingly edited discussion of the Basle I framework and its major fallacies which motivated

Il fait œuvre d’histoire orale en écrivant le récit d’une période à partir de témoignages de personnes qui l’ont vécue ; il fait œuvre d’histoire en

- Variabilité de l’IC50 à la suite de différentes méthodes utilisées pour tenir compte de la liaison protéique 47-50 Quotient inhibiteur normalisé (NIQ) IQ patient/ IQ référence

Univariable analysis of associations between MRSA infection status (i.e. MRSA case and MSSA control) in 181 dogs and cats and attributes of their clinical history (based on